Acadia Healthcare Company, Inc. - Common Stock (ACHC)
45.10
+1.36 (3.11%)
Acadia Healthcare Company is a leading provider of behavioral healthcare services, specializing in the treatment and management of mental health and substance use disorders
With a network of facilities across the United States, Acadia operates a range of inpatient and outpatient programs designed to deliver high-quality care tailored to the unique needs of individuals facing psychological challenges. The company is committed to improving patient outcomes through evidence-based practices, compassionate treatment approaches, and a focus on fostering a supportive recovery environment. Acadia's mission is to enhance the overall well-being of its patients and communities by providing accessible and effective mental health solutions.
KeyBanc anticipates healthcare services stocks will thrive in 2025, with growth driven by higher patient volumes and improving Medicare Advantage policies.
Acadia Healthcare Company, Inc. (NASDAQACHC) today announced that the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference, January 13-16, 2025, in San Francisco, California.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Acadia Healthcare Company, Inc. (“Acadia Healthcare” or the “Company”) (NASDAQACHC) and reminds investors of the December 16, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
LOS ANGELES, CA / ACCESSWIRE / December 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare") (NASDAQACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 30, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 16, 2024.
LOS ANGELES, CA / ACCESSWIRE / December 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
LOS ANGELES, CA / ACCESSWIRE / December 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
RADNOR, PA / ACCESSWIRE / December 14, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare") (NASDAQACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 30, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 16, 2024.
The Law Offices of Frank R. Cruz reminds investors of the upcoming December 16, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Acadia Healthcare Company Inc. (“Acadia” or the “Company”) (NASDAQACHC) securities between February 28, 2020 and October 30, 2024, inclusive (the “Class Period”).
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 16, 2024 to file lead plaintiff applications in securities class action lawsuits against Acadia Healthcare Company, Inc. (NasdaqGS: ACHC), if they purchased the Company’s securities between February 8, 2020 and October 30, 2024, inclusive (the “Class Period”). These actions are pending in the United States District Court for the Middle District of Tennessee.
LOS ANGELES, CA / ACCESSWIRE / December 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Acadia Healthcare Company, Inc. (“Acadia Healthcare”, or the “Company”) (NASDAQACHC) for violations of the federal securities laws on behalf of investors who purchased or acquired Acadia Healthcare common stock between February 28, 2020 and October 18, 2024, inclusive (the “Class Period”).
This extension followed Acadia’s Q3 2024 earnings report and reduced FY 2024 guidance, blaming slower same-store patient day growth of only 3% in October on “the recent headlines and reporting in the media.” The company also reported that it received a subpoena from the SEC. In response, the price of Acadia shares fell about 18% on October 31, 2024.
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. (“Acadia Healthcare” or the “Company”) (NASDAQACHC) in the United States District Court Middle District of Tennessee on behalf of all persons and entities who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and September 26, 2024, both dates inclusive (the “Class Period”). Investors have until December 16, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
RADNOR, Pa. - (NewMediaWire) - December 09, 2024 - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. (“Acadia Healthcare”) (NASDAQACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 18, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 16, 2024.
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. (“Acadia Healthcare”) (NASDAQACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 18, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 16, 2024.
RADNOR, Pa. - (NewMediaWire) - December 07, 2024 - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. (“Acadia Healthcare”) (NASDAQACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 18, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 16, 2024.
